IL33 and hepatocellular carcinoma: For example, local IL-33 production in a mouse model of hepatocellular carcinoma was shown to enhance CD4+ and CD8+ anti-tumor activity (135), warranting a re-evaluation of the use of IL-33-neutralizing drugs in tumor models.